Standout Papers
Immediate Impact
62 standout
Citing Papers
Artificial intelligence in drug development
2025 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Xiaonan Sun being referenced
LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial
2021
Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xiaonan Sun | 495 | 251 | 236 | 444 | 55 | 1.1k | |
| Hubing Wu | 468 | 324 | 330 | 519 | 93 | 1.3k | |
| Kenshiro Shiraishi | 300 | 549 | 268 | 491 | 69 | 1.4k | |
| Xiaoning Luo | 235 | 297 | 203 | 699 | 52 | 1.3k | |
| Antonio Gómez‐Caamaño | 308 | 466 | 133 | 467 | 71 | 1.0k | |
| Ji Hyun Chang | 347 | 287 | 144 | 229 | 83 | 1.1k | |
| Luca Molinaro | 235 | 536 | 223 | 208 | 62 | 1.2k | |
| Bhupinder Sharma | 221 | 257 | 191 | 434 | 79 | 1.0k | |
| Jerzy Jakubowicz | 315 | 263 | 135 | 155 | 55 | 897 | |
| Xu‐Wei Cai | 255 | 501 | 137 | 376 | 50 | 853 | |
| Merina Ahmed | 425 | 675 | 296 | 408 | 43 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...